MMP9 and Hepatic fibrosis: More specifically, MMP‐9‐deficient mice have been reported to exhibit moderate protection against early fibrosis and proteolytic inactive MMP‐9 mutants, acting as TIMP‐1 antagonists in vitro and inhibiting CCl4‐induced liver fibrosis in mice.12, 13